Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
1 file | 909.69 KB
Add to list
  1. Search results
  2. Pre-clinical evaluation of second gen...

Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma

Renate De Smedt (UGent) , Sofie Peirs (UGent) , Julie Morscio (UGent) , Filip Matthijssens (UGent) , Juliette Roels (UGent) , Lindy Reunes (UGent) , Béatrice Lintermans (UGent) , Steven Goossens (UGent) , Tim Lammens (UGent) , Nadine Van Roy (UGent) , et al.
(2018) HAEMATOLOGICA. 104(1). p.e17-e20
Author
Organization
Keywords
SMALL-MOLECULE INHIBITOR, PROTEIN-KINASES, GROWTH

Downloads

  • Download
    e17.full.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 909.69 KB

Citation

Please use this url to cite or link to this publication:

MLA
De Smedt, Renate, et al. “Pre-Clinical Evaluation of Second Generation PIM Inhibitors for the Treatment of T-Cell Acute Lymphoblastic Leukemia and Lymphoma.” HAEMATOLOGICA, vol. 104, no. 1, 2018, pp. e17–20, doi:10.3324/haematol.2018.199257.
APA
De Smedt, R., Peirs, S., Morscio, J., Matthijssens, F., Roels, J., Reunes, L., … Van Vlierberghe, P. (2018). Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma. HAEMATOLOGICA, 104(1), e17–e20. https://doi.org/10.3324/haematol.2018.199257
Chicago author-date
De Smedt, Renate, Sofie Peirs, Julie Morscio, Filip Matthijssens, Juliette Roels, Lindy Reunes, Béatrice Lintermans, et al. 2018. “Pre-Clinical Evaluation of Second Generation PIM Inhibitors for the Treatment of T-Cell Acute Lymphoblastic Leukemia and Lymphoma.” HAEMATOLOGICA 104 (1): e17–20. https://doi.org/10.3324/haematol.2018.199257.
Chicago author-date (all authors)
De Smedt, Renate, Sofie Peirs, Julie Morscio, Filip Matthijssens, Juliette Roels, Lindy Reunes, Béatrice Lintermans, Steven Goossens, Tim Lammens, Nadine Van Roy, Aurore Touzart, Silvia Jenni, Yi-Chien Tsai, Federica Lovisa, Lara Mussolin, Valentina Serafin, Filip Van Nieuwerburgh, Dieter Deforce, Anne Uyttebroeck, Thomas Tousseyn, Birgit Burkhardt, Wolfram Klapper, Barbara De Moerloose, Yves Benoit, Elizabeth Macintyre, Jean-Pierre Bourquin, Giuseppe Basso, Benedetta Accordi, Beat Bornhauser, Jules Meijerink, Peter Vandenberghe, and Pieter Van Vlierberghe. 2018. “Pre-Clinical Evaluation of Second Generation PIM Inhibitors for the Treatment of T-Cell Acute Lymphoblastic Leukemia and Lymphoma.” HAEMATOLOGICA 104 (1): e17–e20. doi:10.3324/haematol.2018.199257.
Vancouver
1.
De Smedt R, Peirs S, Morscio J, Matthijssens F, Roels J, Reunes L, et al. Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma. HAEMATOLOGICA. 2018;104(1):e17–20.
IEEE
[1]
R. De Smedt et al., “Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma,” HAEMATOLOGICA, vol. 104, no. 1, pp. e17–e20, 2018.
@article{8589108,
  author       = {{De Smedt, Renate and Peirs, Sofie and Morscio, Julie and Matthijssens, Filip and Roels, Juliette and Reunes, Lindy and Lintermans, Béatrice and Goossens, Steven and Lammens, Tim and Van Roy, Nadine and Touzart, Aurore and Jenni, Silvia and Tsai, Yi-Chien and Lovisa, Federica and Mussolin, Lara and Serafin, Valentina and Van Nieuwerburgh, Filip and Deforce, Dieter and Uyttebroeck, Anne and Tousseyn, Thomas and Burkhardt, Birgit and Klapper, Wolfram and De Moerloose, Barbara and Benoit, Yves and Macintyre, Elizabeth and Bourquin, Jean-Pierre and Basso, Giuseppe and Accordi, Benedetta and Bornhauser, Beat and Meijerink, Jules and Vandenberghe, Peter and Van Vlierberghe, Pieter}},
  issn         = {{0390-6078}},
  journal      = {{HAEMATOLOGICA}},
  keywords     = {{SMALL-MOLECULE INHIBITOR,PROTEIN-KINASES,GROWTH}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{e17--e20}},
  title        = {{Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma}},
  url          = {{http://dx.doi.org/10.3324/haematol.2018.199257}},
  volume       = {{104}},
  year         = {{2018}},
}
Altmetric
View in Altmetric
Web of Science
Times cited: